Search - tctmd.com

Displaying 101 - 120 of 132

Sort: Relevancy | Date

News Daily News

Long-term Outcomes of ‘Full Metal Jacket’ Stenting Appear Favorable

April 30, 2014

News Daily News

Los Resultados SLF Varían según el Estado de la Diabetes y la Complejidad de la Lesión

Caitlin E. Cox

March 13, 2014

News Daily News

DES Outcomes Vary by Diabetes Status, Lesion Complexity

Caitlin E. Cox

March 13, 2014

Presentation TCT 2013

TCT-21. Prognosis of Clinical Outcomes in Chinese Patients Receiving XIENCE V Everolimus-Eluting Stent with Baseline and Residual Syntax Score: One-Year Results from the...

Presenter: Yuejin Yang

October 29, 2013

Presentation TCT 2013

Yes! With Current DES and Pharmacotherapy, SYNTAX Is Already Obsolete and the Majority of Patients with MVD Can Be Managed with PCI

Presenter: Dean Kereiakes

October 28, 2013

Presentation TCT 2013

SYNTAX COST-EFFECTIVENESS: Final Five-Year Results from a Prospective, Randomized Trial of Paclitaxel-Eluting Stents vs. CABG in Patients with Triple Vessel and Left Main Corona...

Presenter: David Cohen

October 28, 2013

Presentation TCT 2013

Should the Presence of Diabetes Move Treatment Toward CABG Rather Than PCI? Historical Observations and Syntax Score II

Presenter: Patrick Serruys

October 28, 2013

News Daily News

EXECUTIVE: Xience Performs Well in Patients with Less Complex Multivessel Disease

October 15, 2013

News Daily News

EXECUTIVE: Xience Funciona Bien en Pacientes con Enfermedad Multivaso Menos Compleja

October 15, 2013

News Daily News

EXECUTIVE：依维莫司在治疗非复杂多支病变中效果良好

October 15, 2013

News Conference News ACC 2013

Is Nobori NEXT? Biodegradable-Polymer DES Noninferior to EES

Jason Kahn

March 09, 2013

Presentation TCT 2013

Per-Lesion Inter-observer Variability and Impact on Syntax Score

Presenter: Gerardo Nau, Pablo Lamelas, Mariano Albertal, Jorge Belardi, Lucio Padilla, Sebastian Peralta, Fabricio Torrent, Fernando Cura

January 31, 2013

News Daily News

La CABG es Más Rentable a Largo Plazo en Pacientes Diabéticos con Enfermedad Multivaso

Yael L. Maxwell

January 09, 2013

News Daily News

CABG More Cost-Effective in Patients with Diabetes, Multivessel Disease Over Long Term

Yael L. Maxwell

January 09, 2013

Presentation TCT 2012

SYNTAX SCORE II: An Improved Risk Score Based on Clinical and Angiographic Variables

Presenter: Vasim Farooq

October 25, 2012

Presentation TCT 2012

TCT-43. Final Five-year Follow-up of the SYNTAX Trial: Optimal Revascularization Strategy in Patients with Three-vessel Disease

Presenter: A. Pieter Kappetein

October 23, 2012

Presentation TCT 2012

TAXUS: Final Five-Year SYNTAX Results (Entire Study Population)

Presenter: Patrick Serruys

October 22, 2012

Presentation TCT 2012

Multivessel Disease 1: Final Five-Year SYNTAX Results in the MVD Cohort

Presenter: A. Pieter Kappetein

October 22, 2012

News Daily News

Meta-analysis: DES Acceptable but Not Trouble-Free for Left Main Disease

Caitlin E. Cox

August 16, 2012

News Daily News

Meta Análisis: Los SLF son Aceptables aunque No están Exentos de Problemas en la Enfermedad del Tronco Coronario Izdo

Caitlin E. Cox

August 16, 2012

Advertisement

Long-term Outcomes of ‘Full Metal Jacket’ Stenting Appear Favorable

Los Resultados SLF Varían según el Estado de la Diabetes y la Complejidad de la Lesión

DES Outcomes Vary by Diabetes Status, Lesion Complexity

TCT-21. Prognosis of Clinical Outcomes in Chinese Patients Receiving XIENCE V Everolimus-Eluting Stent with Baseline and Residual Syntax Score: One-Year Results from the...

Yes! With Current DES and Pharmacotherapy, SYNTAX Is Already Obsolete and the Majority of Patients with MVD Can Be Managed with PCI

SYNTAX COST-EFFECTIVENESS: Final Five-Year Results from a Prospective, Randomized Trial of Paclitaxel-Eluting Stents vs. CABG in Patients with Triple Vessel and Left Main Corona...

Should the Presence of Diabetes Move Treatment Toward CABG Rather Than PCI? Historical Observations and Syntax Score II

EXECUTIVE: Xience Performs Well in Patients with Less Complex Multivessel Disease

EXECUTIVE: Xience Funciona Bien en Pacientes con Enfermedad Multivaso Menos Compleja

EXECUTIVE：依维莫司在治疗非复杂多支病变中效果良好

Is Nobori NEXT? Biodegradable-Polymer DES Noninferior to EES

Per-Lesion Inter-observer Variability and Impact on Syntax Score

La CABG es Más Rentable a Largo Plazo en Pacientes Diabéticos con Enfermedad Multivaso

CABG More Cost-Effective in Patients with Diabetes, Multivessel Disease Over Long Term

SYNTAX SCORE II: An Improved Risk Score Based on Clinical and Angiographic Variables

TCT-43. Final Five-year Follow-up of the SYNTAX Trial: Optimal Revascularization Strategy in Patients with Three-vessel Disease

TAXUS: Final Five-Year SYNTAX Results (Entire Study Population)

Multivessel Disease 1: Final Five-Year SYNTAX Results in the MVD Cohort

Meta-analysis: DES Acceptable but Not Trouble-Free for Left Main Disease

Meta Análisis: Los SLF son Aceptables aunque No están Exentos de Problemas en la Enfermedad del Tronco Coronario Izdo

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content